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Polypyrimidine-tract-binding protein (PTB) has been shown to bind specifically to the 5 ends of mouse hepatitis virus
(MHV) RNA and its complementary strand. To further characterize the function of PTB in MHV replication, we generated
dominant-negative mutant cell lines that express a full-length PTB or a truncated form of PTB, which includes only the
N-terminal half of the protein, retaining its protein-dimerization domain. The truncated form of PTB was localized in the
cytoplasm, whereas the full-length PTB was present mainly in the nucleus. The truncated form can interact with the full-length
PTB in vitro. We observed that both the full-length and the truncated PTB, when overexpressed, functioned in a dominant-
negative manner in MHV replication. However, the truncated form exhibited more severe effects on syncytia formation, virus
production, and synthesis of viral RNA and viral proteins. To clarify the precise function of PTB in MHV replication, we
dissociated the processes of viral transcription from translation by transfecting different types of MHV defective-interfering
(DI) RNA that contain various reporter genes into these stable cell lines. Transcription of the DI RNA during MHV infection
was greatly inhibited in these cell lines, indicating that PTB modulates MHV transcription. In contrast, translation of the DI
RNA was not affected by PTB depletion in in vitro translation in rabbit reticulocyte lysate or by PTB overexpression in in vivo
translation experiments in MHV-infected cells. Given that PTB interacts with the viral N protein, which is one of theINTRODUCTION
Polypyrimidine-tract-binding protein (PTB), a member
of the heterogeneous nuclear ribonucleoprotein (hnRNP)
family, is a 57-kDa protein that binds to pyrimidine-rich
RNA sequences, which are present mostly in the introns
and untranslated regions of cellular and viral RNA (Ghetti
et al., 1992). As an RNA-binding protein, PTB has four
consensus RNA-recognition motifs (RRM). RRM 1 and 2,
which are in the N-terminal half of PTB, are required for
PTB oligomerization and other protein–protein interac-
tions, whereas RRM 3 and 4, which are in the C-terminal
half of PTB, are necessary for the RNA-binding activity
(Oh et al., 1998). Though PTB is a nuclear protein in the
static state, it can shuttle between the nucleus and
cytoplasm. It has been shown that the N-terminal 60
amino acids within RRM 1 are required for the nuclear
localization of PTB (Li and Yen, 2002; Perez et al., 1997),
but the N-terminal 25 amino acids also contain the nu-
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58clear export signal (NES) (Li and Yen, 2002). The RRM 1
alone localizes exclusively in the nucleus, whereas RRM
1 and 2 is distributed in both the cytoplasm and the
nucleus (Kamath et al., 2001), suggesting that RRM 2
facilitates the nuclear export of PTB. In addition, RRM 3
and 4 may also contribute to the nuclear localization of
PTB, since the wild-type PTB localizes primarily in the
nucleus.
PTB is involved in multiple steps of pre-mRNA pro-
cessing, including tissue-specific splicing (Wagner and
Garcia-Blanco, 2001), mRNA localization in Xenopus oo-
cytes (Cote et al., 1999; Schnapp, 1999), and regulation of
polyadenylation (Moreira et al., 1998). In addition, PTB
has been shown to mediate the export of hepatitis B
virus (HBV) unspliced mRNA from the nucleus (Zang et
al., 2001). Cytoplasmic PTB has been shown to have an
effect on viral and cellular IRES-dependent translation of
RNA (Belsham and Sonenberg, 1996). For example, en-
cephalomyocarditis virus (EMCV) and foot-and-mouth-
disease virus (FMDV) IRES-dependent translation is
abolished by the depletion of PTB from the rabbit reticu-
locyte lysate (RRL) or HeLa cell lysate (Hellen et al., 1993,
1994; Kaminski et al., 1995). In contrast, PTB can inhibit
IRES-dependent Bip mRNA translation (Kim et al., 2000).
Thus, PTB may enhance or inhibit translation, dependingcomponents of the MHV replication complex, PTB may exer
viral RNA as well as other viral and cellular factors in the
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on the type of IRES.
Mouse hepatitis virus (MHV) belongs to the Corona-t its fu
replica
viridae family and contains a single-stranded, 31-kb, pos-
itive-sense RNA (Lai and Cavanagh, 1997). MHV RNA
replication and transcription are carried out in the cyto-
plasm and mediated by its own polymerase as well as
other viral and cellular proteins. Following virus entry into
cell, viral replicase proteins are first synthesized via the
host cellular translational machinery. The viral replicases
then carry out RNA synthesis. A large body of evidence
has demonstrated that several cis- and trans-acting ele-
ments of viral RNA, including the intergenic sequence
(Makino et al., 1991), leader sequence (Zang et al., 2001),
and 3-untranslated region (UTR) (Lin et al., 1996) are
involved in the viral RNA synthesis.
Several cellular proteins have been identified to bind
to these cis-acting RNA regulatory elements (Furuya and
Lai, 1993). These include PTB (Li et al., 1999), hnRNP A1
(Li et al., 1997), mitochondrial aconitase (Nanda and
Leibowitz, 2001), poly(A)-binding protein (PABP) (Spag-
nolo and Hogue, 2000), and several other unidentified
proteins. PTB binds to the UCUAA repeats within the
leader sequence and the RNA complementary to the
3-UTR (c3-UTR) at two different sites (Huang and Lai,
1999; Lai et al., 1999). The PTB binding to the c3-UTR
induced a conformational change in RNA structure
(Huang and Lai, 1999). Mutations of the PTB-binding site
in either 5-leader or c3-UTR inhibited the replication
and transcription of MHV genomic and defective-inter-
fering (DI) RNA, in direct proportion to the extent of
reduction of PTB binding, suggesting that PTB plays a
role in regulating viral RNA synthesis. In contrast, hnRNP
A1 binds to the leader and intergenic sequence (IG) of
negative strand and 3-UTR region of positive strand
(Furuya and Lai, 1993; Li et al., 1997). Site-specific mu-
tation of IG sequence also inhibited the mRNA transcrip-
tion from MHV DI RNA, in direct proportion to the extent
of reduction of hnRNP A1 binding (Li et al., 1997; Zhang
and Lai, 1995). The effect of hnRNP A1 on MHV RNA
transcription was further confirmed in the cell lines ex-
pressing a dominant-negative mutant of hnRNP A1 (Shi
et al., 2000). Although MHV can replicate in a cell line
deficient in hnRNP A1 (Shen and Masters, 2001), recent
studies showed that other hnRNP A1 related proteins
substitute for hnRNP A1 in this cell line (Shi, S. Yu, G.,
and Lai, M. M. C., unpublished data).
To further elucidate the role of PTB in MHV RNA
synthesis, we generated several stable cell lines ex-
pressing the full-length PTB and a truncated form of PTB
that lacks its C-terminal sequence. We demonstrated
that these cell lines function in a dominant-negative
manner in viral replication. The overexpression of the
full-length or the truncated PTB caused severe inhibition
of both viral RNA and viral protein synthesis. We further
established that the primary effect of the PTB overex-
pression was the inhibition of viral RNA synthesis, but
not the translation of viral RNA. These studies estab-
lished that PTB may participate in viral RNA synthesis by
interacting with the viral RNA replication complex.
RESULTS
PTB binds to the 5-untranslated region of MHV RNA
in virus-infected cells
PTB was identified as a cellular protein binding to
MHV RNA by UV-crosslinking experiments using unin-
fected cell extracts (Furuya and Lai, 1993; Li et al., 1999).
Subsequent in vitro binding studies have shown that PTB
binds to the 5-leader sequence and the sequence com-
plementary to the 3-UTR of MHV RNA (Huang and Lai,
1999; Li et al., 1999). To establish that PTB indeed binds
to viral RNA in the virus-infected cells, we immunopre-
cipitated PTB from the MHV-infected cells; the viral RNA
was then detected by RNase protection assay (RPA)
using a 5-UTR-specific probe. We used a DBT stable cell
line that overexpresses a FLAG-tagged PTB (see below)
to increase the amount of PTB for easier detection (Fig.
1). The control experiments showed that an MHV RNA-
specific band was detected by RPA in the virus-infected
DBT lysates, while no protected band was detected in
the uninfected DBT cells (Fig. 1, lanes 2 and 3). Immu-
noprecipitation of PTB with either anti-PTB antibody or
anti-FLAG antibody pulled down the viral RNA (Fig. 1,
lanes 5 and 6). In contrast, anti-VSV-G protein or antiactin
FIG. 1. In vivo binding of PTB to MHV RNA in the PTB-overexpressing cell line as detected by RPA. Cytoplasmic extracts from MHV-infected DBT
cells were immunoprecipitated with beads only (lane 4) or specific antibodies (lanes 5–9), and the RNA from the precipitates were examined by RPA
using a negative-strand 5-UTR RNA (270 nt) as a probe. The predicted size of the protected band is 250 nt long. Lane 1 indicates 1% unhybridized
probe only. As a control, total RNA from uninfected and MHV-JHM-infected DBT cells without prior immunoprecipitation was used directly for RPA
(lanes 2 and 3).
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antibodies yielded only background signals similar to
that using the bead only (Fig. 1, lanes 4, 8, and 9). Anti-N
antibody also precipitated the viral RNA, consistent with
the finding that N protein binds to the 5-UTR of MHV
RNA (Stohlman et al., 1988) (Fig. 1, lane 7). These results
indicate that PTB does bind to MHV RNA in the virus-
infected cells.
PTB interacts with the viral N protein in vitro
and in vivo
Next, we asked whether PTB interacts with viral pro-
teins in the virus-infected cells. Since N protein binds to
5-UTR, and PTB also does so, we hypothesized that
there might be an interaction between PTB and the N
protein. We first tested in vitro interaction between PTB
and N by GST pull-down assay (Fig. 2A). In vitro trans-
lated, [35S]methionine-labeled N protein was pulled
down by GST-PTB, but not by GST (Fig. 2A, lanes 2 and
3). Under the same conditions, N protein was also pulled
down by GST-hnRNP A1, confirming the previous report
(Wang and Zhang, 1999) (Fig. 2A, lane 4).
We further examined whether this interaction occurred
in the virus-infected cells. PTB-overexpressing DBT cells
were infected with MHV; at 8 h postinfection (p.i.), cyto-
plasmic extracts were immunoprecipitated with anti-PTB
antibody, followed by immunoblotting with anti-N anti-
body (Fig. 2B). In accordance with the in vitro GST pull-
down assay, N protein was specifically coimmunopre-
cipitated with PTB, proving that PTB interacts with N
protein in the virus-infected cells (Fig. 2B, lane 5). Under
the same conditions, neither anti-VSV-G protein antibody
nor the bead alone brought down the N protein (Fig. 2B,
lanes 3 and 6). Interaction between the endogenous PTB
and the N protein was also demonstrated in DBT cells
without PTB overexpression, although the background
was higher in this case (data not shown). These results
suggest that PTB may form a ribonucleoprotein complex
with viral RNA, N protein, and other viral and cellular
proteins.
Analysis of stable cell lines that express the
full-length and truncated PTB
To assess the function of PTB in MHV replication, we
generated several stable DBT cell lines expressing ei-
ther a FLAG-tagged full-length PTB (F-PTB) or a C-termi-
nus-truncated PTB (N-PTB). The truncated form of PTB
includes only the two N-terminal RRM motifs (RRM 1 and
RRM 2), which are responsible for the oligomerization of
PTB and contain the signal for nucleocytoplasmic shut-
tling, but lacks the C-terminal half, which is required for
the RNA-binding activity of PTB (Oh et al., 1998) (Fig. 3A).
Both F-PTB (57 kDa) and N-PTB (29 kDa) were well
expressed in the stable cell lines, as shown by immuno-
blotting with anti-FLAG antibody (Fig. 3B). Overexpres-
sion of the F-PTB or N-PTB did not affect the cell growth
kinetics (Fig. 3C).
The overexpressed N-PTB localizes predominantly in
cytoplasm and can bind to F-PTB in vitro
Next, we determined the subcellular localization of
the overexpressed F-PTB and N-PTB. Immunofluores-
cence staining showed that F-PTB was localized in the
nucleus, similar to the endogenous PTB, while N-PTB
was predominantly in the cytoplasm, although a small
fraction was observed in the nucleus (Fig. 3D). Thus, in
the cytoplasm, the amount of N-PTB likely far exceeds
that of the endogenous PTB, rendering it likely that
N-PTB could affect the cytoplasmic functions of PTB.
We hypothesized that the truncated PTB might form a
dimer with the endogenous PTB, resulting in disrup-
tion of the normal functions of cytoplasmic PTB. To
examine this possibility, we carried out an in vitro
binding experiment to test the possible interaction of
N-PTB with F-PTB. As seen in Fig. 3E, GST-PTB binds
to both F-PTB and N-PTB, though the binding ability of
N-PTB was slightly weaker than that of F-PTB. The low
protein binding ability of N-PTB is consistent with the
report that, even though RRM 2 contributes the most to
PTB dimerization, other RRM domains help stabilize
FIG. 2. Interaction between PTB and N in vitro and in PTB-overex-
pressing cell line. (A) In vitro binding between PTB and N. GST (lane 2),
GST-PTB (lane 3), and GST-hnRNP A1 (lane 4) were incubated with in
vitro translated, 35S-labeled N protein. After washing, samples were
separated by SDS–PAGE on 10% polyacrylamide gels, and signals were
detected by autoradiography. Lane 1 indicates 10% of input N protein.
(B) In vivo binding between PTB and N. Cytoplasmic extracts from
MHV-JHM-infected DBT cells were immunoprecipitated with beads
(lane 6), anti-PTB antibody (lanes 4 and 5), and anti-VSV-G protein
antibody (lanes 2 and 3). The immunoprecipitated proteins were sep-
arated by SDS–PAGE on 10% polyacrylamide gels and detected by
immunoblotting with a rabbit polyclonal antibody against whole MHV
virion (1:3000 dilution). Lane 1 indicates 10% input of the total lysates.
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the dimer (Perez et al., 1997). Nonetheless, because of
its high expression level in the cytoplasm, N-PTB likely
can sequester the endogenous, cytoplasmic PTB by
forming a dimer with F-PTB and thereby influence the
normal functions of PTB in the cytoplasm.
Syncytia formation and virus production are retarded
in PTB-overexpressing stable cell lines
We next examined the possible effects of F-PTB and
N-PTB on virus replication. To begin with, we investi-
FIG. 3. Characterization of cell lines overexpressing the full-length PTB and truncated PTB. (A) Structure of the full-length PTB (F-PTB) and truncated
PTB (N-PTB). RRM: RNA recognition motif. (B) Protein expression of the full-length PTB and truncated PTB in the stable cell lines. Lysates were used
for immunoblotting with anti-FLAG antibody. Two different clones each of the vector control cell (lanes 1 and 2), F-PTB (lanes 3 and 4), and N-PTB
(lanes 5 and 6)—expressing cell lines were examined. (C) Growth kinetics of the different cell lines. Same numbers of cells (105) were seeded onto
10-cm plates and counted every 24 h. (D) Subcellular localization of F-PTB and N-PTB in the stable cell lines. Cells were stained with anti-FLAG
antibody. (E) In vitro binding between F-PTB and N-PTB. In vitro translated, 35S-labeled F-PTB or N-PTB were incubated with GST (lanes 1 and 2) or
GST-PTB (lanes 5 and 6) and separated by SDS–PAGE. Lanes 3 and 4 indicate 10% input of the in vitro translated F-PTB and N-PTB.
FIG. 4. Inhibition of syncytia formation and virus production in the stable cell lines. (A) Vector, F-PTB-, and N-PTB-overexpressing cell lines were
infected with MHV-JHM, and syncytia formation was observed at various time points (7, 15, and 24 h p.i.). (B) Virus titers in the supernatant were
measured at various time points (7, 9, 14, and 25 h) after infection by plaque assay on DBT cells.
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gated the morphological changes induced by MHV in-
fection in these stable cell lines (Fig. 4A). As compared
with the vector control cells, the N-PTB-expressing sta-
ble cell line showed significantly delayed syncytia for-
mation at every time point p.i., especially at the earlier
time points, indicating that N-PTB functions in a domi-
nant-negative manner in viral replication. Surprisingly,
overexpression of F-PTB also caused delayed syncytia
formation, although to a lesser extent than N-PTB did.
The dominant-negative effect of F-PTB is similar to the
“squelching effect” commonly observed with the overex-
pression of transcription factors (Katja and Hurt, 2001);
thus, the overexpression of PTB may impair virus repli-
cation in a dominant-negative manner by titrating out
some factors involved in virus replication.
Similar to cellular morphology, virus production also
was inhibited by nearly 100-fold in the N-PTB stable cell
lines at 7–15 h p.i. and slightly less in F-PTB stable cell
line (Fig. 4B). At 25 h p.i., the virus titer from the PTB-
overexpressing cell lines became higher than that from
the vector control cells, probably due to the fact that the
control cells have already completely lysed; thus, the
virus particles could have been inactivated during the
long incubation period.
The synthesis of viral RNA and proteins is inhibited in
the F-PTB and N-PTB stable cell lines
Next, we examined the effect of F-PTB and N-PTB on
viral RNA and protein synthesis. For viral RNA synthesis,
cells were labeled with [3H]uridine for 1 h in the pres-
ence of actinomycin D (Fig. 5A). In the vector control
cells, viral RNA synthesis started to increase from 6 h p.i.
and peaked at 10 h p.i. In contrast, in both the F-PTB- and
the N-PTB-expressing stable cell lines, maximum incor-
poration of [3H]uridine occurred at 12 h p.i., and the
amounts of incorporated uridine were at least 2.5-fold
less than that in the vector control cells. This delayed
and reduced uridine incorporation in the F-PTB and N-
PTB stable cell lines indicated that overexpression of
PTB may affect directly viral RNA synthesis. To further
determine whether all viral RNA species were affected
by the overexpression of F-PTB and N-PTB, Northern
blotting experiments were performed. The results
showed that all of the MHV RNAs were reduced in the
F-PTB and N-PTB stable cell lines at 7 h p.i. as compared
with that in the vector control cells (Fig. 5B). At 15 h p.i.,
the amounts of all viral RNA species increased in the
F-PTB and N-PTB stable cell lines, but were still less than
that in the control cells. At 24 h p.i., only a trace amount
of viral RNAs was detected in the vector control cells due
to the loss of the dead cells. In combination with the
[H3]uridine incorporation experiment, this result showed
that viral RNA synthesis is inhibited in both the F-PTB
and the N-PTB stable cell lines.
We further examined the effect of PTB on viral protein
synthesis. We examined the expression of N protein by
immunoblotting at various time points (Fig. 5C). The N
protein was detected from 7 h p.i. and peaked at 14 h p.i.
in the vector control cells. However, in the F-PTB and
N-PTB stable cell lines, the detection of N protein began
later (weakly visible at 7 h p.i. in the F-PTB cells and at
9 h p.i. in the N-PTB cells) and peaked at 24 h p.i.
FIG. 5. Inhibition of viral RNA and protein synthesis in the stable cell
lines. (A) Viral RNA synthesis in the various cell lines as determined by
[3H]uridine incorporation. At various time points p.i., cells were pre-
treated with 5 g/ml actinomycin D for 1 h and labeled with [3H]uridine
for another 1 h. TCA-precipitable counts were determined. The figure is
the representative of three experiments. (B) Northern blotting analysis
of the cytoplasmic viral RNAs at various time points (7, 15, and 24 h) p.i.
32P-labeled antisense mRNA 7 was used as a probe. Numbers indicate
various MHV mRNA species. (C) Kinetics of synthesis of viral N protein.
Immunoblotting was done using a monoclonal anti-N antibody.
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From these experiments, we concluded that PTB af-
fects both viral RNA and protein synthesis either directly
or indirectly.
PTB directly regulates viral RNA transcription, but not
viral translation
The ability of PTB to retard both viral RNA and protein
synthesis could be due to the possibilities that PTB is
directly involved in both viral transcription and translation
or that PTB affects transcription, which, in turn, affects
translation, or vice versa. To distinguish these possibili-
ties, we designed experiments to examine transcription/
replication and translation separately. First, we assessed
the transcriptional effect of PTB using a DI reporter RNA,
25CAT RNA (Liao et al., 1995), in which the CAT gene
cannot be translated unless a subgenomic mRNA initi-
ated from the inserted intergenic sequence is tran-
scribed in the presence of MHV infection; thus, the ex-
pression of CAT activity mirrors the transcription of a
subgenomic mRNA from this DI RNA (Fig. 6A). PTB-
overexpressing stable cell lines were infected with MHV
and transfected with 25CAT RNA. At 8 h p.i., CAT activity
was fourfold lower in the N-PTB stable cell line than in
the vector control cells (Fig. 6B). In the F-PTB stable cell
line, CAT activity was also inhibited, though to a lesser
extent.
Next, we examined whether PTB directly affected
translation of viral RNA. For this purpose, we performed
in vitro immunodepletion of PTB from RRL (Ali and Sid-
diqui, 1995; Hellen et al., 1993); the immunodepleted
lysates were used for translation of a natural DI RNA
DE25 (Makino et al., 1988) (Fig. 7A, top), in which parts of
MHV ORF1a and 1b are fused in-frame to ORF7 encoding
the N protein. In contrast to the CAT gene in 25CAT RNA,
this fusion protein can be translated directly from the
DE25 RNA into a 85-kDa protein without prior mRNA
transcription. The RNA structure regulating the transla-
tion of this protein mimics that of the wild-type MHV
genomic RNA. RRL was incubated with beads coated
with anti-PTB antibody. Immunoblotting showed that the
endogenous PTB was completely depleted from the ly-
sate (Fig. 7A, bottom, left). In vitro translation of 25CAT DI
RNA in this lysate showed that PTB depletion did not
affect translation. However, this RRL had been pretreated
with micrococcal nucleases to remove most of the en-
dogenous cellular mRNAs, thus allowing exclusive trans-
lation of the exogenous RNA; it is possible that PTB is
required when translation of viral RNA takes place in the
presence of competing cellular mRNAs. To exclude this
possibility, we tested another RRL without prior nuclease
pretreatment so that the viral RNA has to compete with
cellular mRNAs for translation. Under this condition, PTB
depletion also did not have any effect on the DI RNA
translation, although the immunodepletion procedures
did reduce the overall translation efficiency nonspecifi-
cally (Fig. 7A, bottom, right).
We further tested the possible translational effect of
PTB in the stable cell lines. For this purpose, we con-
structed another reporter DI RNA, which contains the
authentic MHV 5- and 3-UTR and expresses luciferase
as a reporter (Fig. 7B, top). The luciferase ORF is fused
with the ORF1a of MHV RNA, so that the RNA element
regulating the translation of luciferase closely mimics
that of the natural MHV RNA. This RNA was transfected
into the F-PTB and N-PTB stable cell lines; at 8 h post-
transfection, luciferase activity in the lysates was as-
sayed (Fig. 7B, bottom). No difference in luciferase ac-
tivity was observed between the vector control cells and
the stable cell lines expressing F-PTB or N-PTB. We also
expressed F-PTB and N-PTB transiently in a human em-
bryogenic kidney cell line, 293A cells, using plasmids
under the control of a cytomegalovirus immediate early
promoter, followed by transfection of MHV-UTR-LUC
RNA; again, no difference in luciferase activity was ob-
served (data not shown). Based on the in vitro and in vivo
results, we concluded that PTB does not affect MHV RNA
translation directly.
To examine whether PTB affects MHV RNA translation
during MHV infection, we further performed the transla-
tion study in the MHV-infected PTB stable cell lines.
F-PTB- and N-PTB-overexpressing cell lines were in-
fected with MHV and transfected with MHV-UTR-LUC
FIG. 6. The effects of PTB on mRNA synthesis from an MHV DI RNA.
(A) Organization of 25CAT DI RNA. L: leader sequence; IG: MHV
intergenic sequence; CAT: chloramphenicol acetyl transferase. The
diagram is not drawn to scale. (B) CAT activity in the vector control,
F-PTB-, and N-PTB-overexpressing cell lines. MHV DI 25CAT RNA was
transfected into MHV-JHM-infected stable cell lines, and CAT activity in
the lysate was determined at 8 h posttransfection. Error bars represent
standard deviations.
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RNA 1 h later. Luciferase assays were performed at 8 h
postinfection. Even in the presence of MHV infection,
no difference in luciferase activity was observed
(Fig. 7C), indicating that PTB has no effect on MHV
translation.
Combining the transcription and translation experi-
ments, we conclude that the effects of PTB overexpres-
sion on MHV RNA synthesis were not due to the indirect
effect of inhibition of viral protein synthesis. Therefore,
PTB plays a direct role in MHV RNA synthesis.
DISCUSSION
Our previous studies have shown that PTB binds to the
5-UTR of both positive- and negative-strand MHV RNA,
that PTB binding to the positive strand requires the
UCUAA repeats sequence at the 5-end leader, and that
its binding to the negative-strand RNA caused conforma-
tional change of the RNA (Huang and Lai, 1999; Li et al.,
1999). Furthermore, RNA mutations that caused reduc-
tion of PTB binding reduced the mRNA transcription from
an MHV DI RNA, suggesting that PTB may regulate MHV
RNA synthesis. In this study, we used dominant-negative
mutants of PTB to demonstrate the direct involvement of
PTB in viral RNA synthesis. We showed that the expres-
sion of a dominant-negative mutant of PTB inhibited viral
RNA synthesis, but did not affect viral RNA translation.
Thus, the primary effect of PTB appears to be on viral
RNA synthesis. Combined with the finding that PTB in-
FIG. 7. The effects of PTB on the translation of DI RNA. (A) In vitro translation. The diagram shows the structure of DE25 RNA. After the rabbit
reticulocyte lysate (either treated or untreated with micrococcal nuclease) was depleted of the endogenous PTB, it was used for in vitro translation
of DE25 DI RNA (top). The lysate was also used for immunoblotting for PTB (bottom). (B) In vivo translation in the stable cell lines. Diagram shows
the structure of MHV-UTR-LUC RNA. In vitro transcribed MHV-UTR-LUC DI RNA was transfected into the various cell lines, and the lysates were
assayed for luciferase activity at 8 h posttransfection. (C) In vivo translation in MHV-infected stable cell lines. Cells were infected with MHV-JHM and,
at 1.5 h p.i., transfected with MHV-UTR-LUC DI RNA. Luciferase activity was assayed at 8 h posttransfection.
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teracts with viral N protein, which also binds to 5-UTR
(Stohlman et al., 1988) and may modulate viral RNA
synthesis (Compton et al., 1987), our findings suggest
that PTB is complexed with the viral transcription/repli-
cation machinery. This may represent another new cyto-
plasmic function of PTB in the cells.
Despite the binding of PTB to the 5-UTR of MHV
genomic RNA, our study showed that PTB is not directly
implicated in MHV translation. The 5-UTR has been
shown to regulate the translation of MHV RNA; specifi-
cally, the N protein binding to the 5-UTR enhanced the
translation of MHV RNA (Tahara et al., 1998). However,
since genomic and subgenomic mRNAs of MHV are
capped, polyadenylated, and translated by a cap-depen-
dent translation pathway, they may not need noncanoni-
cal factors for efficient translation. Nevertheless, we
could not rule out the possibility that PTB may regulate
MHV translation under certain conditions. In influenza A
virus, 5-UTR of viral RNA also is not necessary for the
efficient translation (Cassetti et al., 2001).
In this study, we established stable cell lines overex-
pressing F-PTB or N-PTB and showed that the truncated
form of PTB functions in a dominant-negative manner in
MHV RNA synthesis. There are several possible mech-
anisms for the dominant-negative effects of the truncated
PTB. First, since this truncated form has only RRM 1 and
2, which are responsible for dimerization and protein–
protein interaction, N-PTB may interact with the wild-type
PTB, resulting in dysfunction of the endogenous PTB.
Our in vitro binding experiment between F-PTB and N-
PTB supports this possibility (Fig. 3E). Second, N-PTB
may sequester other RNA-binding proteins, such as
hnRNP A1 and other unidentified proteins, which may be
involved in MHV transcription/replication. The third pos-
sibility is that the overexpressed N-PTB may bind to viral
RNA, displacing the cytoplasmic, endogenous PTB,
since N-PTB retains a weak RNA-binding activity (Oh et
al., 1998). The fourth possibility is that N-PTB may inter-
act with the N protein, thus blocking the interaction
between the endogenous PTB and N proteins. In any
case, the amount of the overexpressed N-PTB in the
cytoplasm likely far exceeds that of the cytoplasmic,
endogenous PTB, enough to disturb the normal functions
of PTB in the cytoplasm. On the other hand, it is puzzling
why the wild-type PTB also functions in a dominant-
negative manner. It is possible that the recombinant PTB,
which has a FLAG tag, may be less efficient in its bio-
logical activity than the endogenous PTB. Furthermore,
overexpression of PTB may titrate out one or more com-
ponents of the RNA replication complex, resulting in the
inhibition of replication/transcription, in a mechanism
akin to the squelching effects frequently observed for the
overexpressed transcription factors. It is intriguing to
note that overexpression of a truncated form of hnRNP
A1 also inhibited MHV RNA synthesis, but overexpres-
sion of the full-length hnRNP A1 accelerated MHV RNA
synthesis (Shi et al., 2000). This difference may reflect
the difference in the abundance and protein-interacting
properties of these two hnRNPs. Multiple hnRNP A1
related proteins exist, most of which can interact with
MHV RNA in a similar manner to hnRNP A1 (Shi et al.,
unpublished data). Thus, hnRNP A1 may be more difficult
to titrate out.
The mechanism by which PTB shuttles between the
nucleus and cytoplasm is still not clear. Mapping studies
have shown that both NLS and NES are confined to the
N-terminus of PTB and overlap in sequence. However, it
is unlikely that the import/export of PTB is determined by
the primary sequence alone. Considering that N-PTB has
both NLS and NES and predominantly localizes in the
cytoplasm, we speculate that the RRM 3 and 4 domains
may affect the localization of the protein by changing its
overall protein conformation or RNA-binding properties
to facilitate nuclear localization. Given that a truncated
mutant of PTB consisting of only RRM3 and RRM4 also
localizes in the cytoplasm (Huang, P., Choi, K., and Lai,
M. M. C., unpublished data), it is likely that the localiza-
tion of PTB in the cells is determined by multiple factors
besides the NLS/NES signals, such as the neighboring
sequence, RNA-binding properties, and interaction with
the import/export machinery.
Although it is not clear how much PTB exists in the
cytoplasm in the static state, it is possible that in certain
situations, such as viral infection or in the absence of
cellular RNA transcription, PTB may relocalize from the
nucleus to cytoplasm to carry out its cytoplasmic func-
tions. Recently, it has been shown that actinomycin D
treatment or poliovirus infections induced the movement
of PTB from the nucleus to the cytoplasm (Back et al.,
2002). We have also studied possible PTB relocalization
during MHV infection, but we could not demonstrate
unequivocally the relocalization of PTB by immunofluo-
rescence staining or immunoblotting methods. One pos-
sible explanation is that the existing cytoplasmic PTB is
sufficient for the function of PTB in MHV transcription/
replication; alternatively, our immunostaining and immu-
noblotting procedure may not be sensitive enough to
detect the subtle movements of PTB.
So far, there have been at least four cellular proteins
identified to bind to the 5- and 3-UTR of MHV RNA and
participate in MHV RNA synthesis. These are hnRNP A1,
PTB, mitochondrial aconitase (Nanda and Leibowitz,
2001), and poly(A)-binding protein (Spagnolo and Hogue,
2000). Although a recent study using an hnRNP A1 defi-
cient cell line claimed that hnRNP A1 is not necessary for
MHV replication (Shen and Masters, 2001), our recent
study showed that, in this particular cell line, other
hnRNP A1 related proteins substitute for hnRNP A1 (Shi,
S., Yu, G., and La, M. M. C., unpublished data). In the
current study, we further demonstrated the modulating
role of PTB in MHV RNA synthesis.
We propose several possible mechanisms for the in-
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volvement of PTB in MHV RNA transcription and replica-
tion, which are not mutually exclusive. First, PTB may
facilitate the recruitment of transcription/replication fac-
tors at the replication site, through the protein–protein
interacting domain. Second, PTB may change the con-
formation of viral RNA into one that is more favorable for
replication and transcription, probably functioning as an
RNA chaperon to unfold the highly structured untrans-
lated region. This proposal is supported by the previous
report that PTB binds to 5-UTR of MHV negative-strand
RNA and alters its conformation (Huang and Lai, 1999).
Finally, PTB may mediate the 5–3 crosstalk by interact-
ing with hnRNP A1 proteins (Huang and Lai, 2001) or its
related proteins, causing the circularization of viral ge-
nome, which may help virus replication. This genomic
circularization and its importance in viral RNA replication
have been reported for poliovirus (Herold and Andino,
2001). More experiments should be done to prove that




DBT cell (Hirano et al., 1974), a mouse brain astrocy-
toma cell line, was cultured in Eagle’s minimal essential
medium (MEM) supplemented with 7% newborn calf se-
rum (NCS), 10% tryptose phosphate broth, and strepto-
mycin-penicillin. MHV-JHM was amplified in DBT cells
and maintained in MEM containing 1% NCS.
Establishment of stable cell lines
DBT cells were transfected with pcDNA3.1-FLAG-F-
PTB, pcDNA3.1-FLAG-N-PTB, or pcDNA3.1 empty vector
using DOTAP reagents (Boehringer Mannheim, Indianap-
olis, IN). After 4 h, the transfected cells were incubated in
the presence of 500 g/ml G418 (Omega Scientific, Tar-
zana, CA) for 10 days. Individual surviving cells were
selected and cultured for 2 weeks before screening for
the expression of the recombinant proteins.
Antibodies
The mouse hybridoma cell, BB7, which produces anti-
PTB monoclonal antibody, was purchased from ATCC
(Manassas, VA). The hybridoma cells were cultured for 3
days and antibodies were collected from the supernatant
and purified by T-gel purification kit (Pierce, Rockford, IL).
The monoclonal antibodies against VSV-G protein and
actin, and the rabbit polyclonal antibody against FLAG
were purchased from Sigma (St. Louis, MO).
Immunoprecipitation and ribonuclease protection
assay (RPA)
The PTB-overexpressing stable cell lines were cul-
tured in 10-cm plates. At 80% confluency, cells were
infected with MHV-JHM at an m.o.i. of 10. At 8 h p.i., cells
were rinsed with PBS once and lysed with Buffer K (20
mM Tris–HCl pH 7.5, 100 mM NaCl, 0.2 mM EDTA pH 8.0).
After incubation on ice for 30 min, the lysates were
passed through a G21 needle five times and centrifuged
at 4000 rpm for 5 min. The supernatant was incubated
with the various antibodies for 2 h at 4°C and with
Protein A–Sepharose beads (Zymed Laboratories Inc.,
San Francisco, CA) for an additional 2 h. The beads were
then washed five times with buffer K and used for RNA
extraction by incubating with the RNA elution buffer (0.3
M Na acetate pH 5.2, 0.2% SDS, 1 mM EDTA pH 8.0, 10
g/ml proteinase K) for 10 min at 65°C. The eluted RNA
was further extracted with phenol/chloroform (Ambion,
Austin, TX) and precipitated with ethanol.
To prepare the RPA probe, the 5-UTR region (nt 77–
327 from the 5-end) plus 38 extra nucleotides containing
the T7 promoter was amplified from the purified MHV-
JHM viral RNA by RT-PCR using the appropriate primers;
the PCR product was used directly for in vitro transcrip-
tion. In vitro transcription and RPA were done using RPA
III kit from Ambion.
Immunofluorescence staining
Cells were fixed with 4% formaldehyde for 15 min at
room temperature and permeabilized with ice-cold ace-
tone for 5 min at 20°C. Then, cells were washed three
times with PBS and incubated with the primary antibody
for 1 h at room temperature. After washing with PBS
three times, cells were incubated with the FITC-conju-
gated secondary antibody (Jackson Immunoresearch,
West Grove, PA) for 1 h and mounted.
GST pull-down assay
GST-PTB was immobilized onto the glutathione sepha-
rose beads (Pierce). In vitro translated, 35S-labeled pro-
teins were added and incubated for 2 h at 4°C in GST-
binding buffer (40 mM HEPES pH 7.5, 100 mM KCl, 20
mM 2-mercaptoethanol) containing 0.3% NP-40. After
binding, beads were washed with the same buffer con-
taining 0.3% NP-40 five times and the bound proteins
were eluted, separated by SDS–PAGE on 10% polyacryl-
amide gels, and detected by autoradiography.
[3H]-uridine labeling of viral RNA
RNA labeling was performed as described previously
(Shi et al., 2000). In brief, cells were infected with MHV-
JHM at an m.o.i. of 2. At various time points postinfection
(7, 9, 11, 13, 15, and 24 h), cells were treated with 5 g/ml
actinomycin D for 1 h prior to the addition of [3H]-uridine
(100 Ci/ml) (NEN, Boston, MA). After incubation with
[3H]-uridine for 1 h, cytoplasmic extracts were prepared,
spotted on 3MM paper, and washed with 5% trichloro-
acetic acid (TCA). The radioactivity on the paper was
counted using a Beckman scintillation counter.
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CAT assay of DI RNA
Transcription assay of 25CAT RNA based on CAT ac-
tivity was performed as described previously (Liao and
Lai, 1994). Briefly, plasmid p25CAT was linearized by
XbaI and transcribed by T7 RNA polymerase. DBT cells
were infected with JHM and, at 1 h p.i., transfected with
5 g of 25CAT RNA using DOTAP. After an 8-h incubation,
cells were collected and freeze/thawed three times. After
centrifugation at 12,000 rpm for 10 min to remove cell
debris, the supernatant was used for CAT assay as
described previously (Lin et al., 1996).
Immunodepletion and in vitro translation
To coat Protein A–Sepharose beads with antibodies,
beads were first rinsed with PBS containing BSA (0.1
mg/ml) three times. Fifty microliters of the washed
beads (50% slurry) was incubated with 10 l of the
mouse monoclonal antibody against PTB (BB7) (1:100
dilution) for 2 h at 4°C, and unbound antibody was
washed away from the beads. The antibody-coated
beads were mixed with 200 l rabbit reticulocyte ly-
sate (RRL) (Promega, Madison, WI) and incubated for
2 h at 4°C. Beads were removed from RRL, and the
depletion procedure was repeated three times. After
depletion, 3 l RRL was used for immunoblotting and
20 l RRL was used for in vitro translation. For in vitro
translation, the in vitro transcribed, capped DI RNA
was generated using mMessage machine kit from
Ambion. In vitro translation was performed according
to the manufacturer’s instruction (Promega). In vitro
translated proteins were separated by SDS–PAGE on
10% polyacrylamide gels and signals were detected by
autoradiography.
Construction of MHV-UTR-LUC, RNA transfection, and
luciferase assay
pGL3-basic vector (Promega) was used as a luciferase
reporter. MHV 5-UTR (184 nt) plus 54 nucleotides from
the very N-terminus of ORF1a and 3-UTR (400 nt), in-
cluding poly(A) tail, were amplified from the purified
MHV-JHM RNA by RT-PCR using appropriate primers and
cloned into pGL3-basic vector.
The construct was linearized with EcoRV prior to in
vitro transcription. In vitro transcribed LUC DI RNA (5 g)
was transfected into the cells using DMRIE-C reagent
(Invitrogen, Carlsbad, CA). At 8 h posttransfection, cells
were harvested and used for luciferase assay, using the
luciferase assay system from Promega.
For translation study in MHV-infected cells, cells were
infected with MHV-JHM and, at 1 h p.i., cells were trans-
fected with 5 g of LUC DI RNA. Luciferase activity was
assayed at 8 h posttransfection.
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